KIDINS220
Basic information
Region (hg38): 2:8721081-8837630
Links
Phenotypes
GenCC
Source:
- spastic paraplegia, intellectual disability, nystagmus, and obesity (Strong), mode of inheritance: AD
- spastic paraplegia, intellectual disability, nystagmus, and obesity (Supportive), mode of inheritance: AD
- ventriculomegaly and arthrogryposis (Strong), mode of inheritance: AR
- spastic paraplegia, intellectual disability, nystagmus, and obesity (Strong), mode of inheritance: AD
- ventriculomegaly and arthrogryposis (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spastic paraplegia, intellectual disability, nystagmus, and obesity (SINO); Ventriculomegaly and arthrogryposis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Craniofacial; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic | 27005418; 28934391; 32909676; 33205811 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (724 variants)
- KIDINS220-related_disorder (420 variants)
- Inborn_genetic_diseases (170 variants)
- Spastic_paraplegia,_intellectual_disability,_nystagmus,_and_obesity (64 variants)
- Ventriculomegaly_and_arthrogryposis (24 variants)
- not_specified (21 variants)
- Intellectual_disability (2 variants)
- Obesity (1 variants)
- Cerebral_palsy (1 variants)
- See_cases (1 variants)
- KCNA1-related_disorder (1 variants)
- Hereditary_spastic_paraplegia (1 variants)
- Kabuki_syndrome_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIDINS220 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020738.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 248 | 7 | 259 | ||
| missense | 2 | 1 | 512 | 52 | 3 | 570 |
| nonsense | 10 | 7 | 7 | 24 | ||
| start loss | 0 | |||||
| frameshift | 13 | 17 | 11 | 41 | ||
| splice donor/acceptor (+/-2bp) | 5 | 16 | 2 | 23 | ||
| Total | 25 | 30 | 550 | 302 | 10 |
Highest pathogenic variant AF is 0.000015488873
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| KIDINS220 | protein_coding | protein_coding | ENST00000256707 | 29 | 112353 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0736 | 0.926 | 124725 | 0 | 70 | 124795 | 0.000280 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.26 | 780 | 979 | 0.797 | 0.0000528 | 11608 |
| Missense in Polyphen | 271 | 419.05 | 0.6467 | 5196 | ||
| Synonymous | 0.222 | 362 | 367 | 0.985 | 0.0000213 | 3451 |
| Loss of Function | 6.41 | 20 | 83.0 | 0.241 | 0.00000444 | 1018 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00198 | 0.00194 |
| Ashkenazi Jewish | 0.0000993 | 0.0000993 |
| East Asian | 0.000287 | 0.000278 |
| Finnish | 0.0000475 | 0.0000464 |
| European (Non-Finnish) | 0.000224 | 0.000221 |
| Middle Eastern | 0.000287 | 0.000278 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism. Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. Plays a role in nerve growth factor (NGF)- induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth. May play a role in neurotrophin- and ephrin-mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity). Modulates stress- induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway. {ECO:0000250, ECO:0000269|PubMed:18089783}.;
- Disease
- DISEASE: Spastic paraplegia, intellectual disability, nystagmus, and obesity (SINO) [MIM:617296]: An autosomal dominant syndrome characterized by rapid growth in infancy, obesity, global developmental delay, intellectual disability, spastic paraplegia, ocular defects, and dysmorphic facial features. {ECO:0000269|PubMed:27005418}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Neurotrophin signaling pathway - Homo sapiens (human);Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Signal Transduction;ARMS-mediated activation;Prolonged ERK activation events;Signalling to ERKs;Signaling by NTRK1 (TRKA);Signaling by NTRKs;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.588
Intolerance Scores
- loftool
- 0.623
- rvis_EVS
- -2.25
- rvis_percentile_EVS
- 1.3
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.675
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kidins220
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- activation of MAPKK activity;in utero embryonic development;positive regulation of neuron projection development;nerve growth factor signaling pathway;dendrite morphogenesis;cellular response to nerve growth factor stimulus
- Cellular component
- late endosome;cytosol;membrane;integral component of membrane;protein-containing complex
- Molecular function
- protein kinase regulator activity;PDZ domain binding